U.S. Markets closed

Elite Pharmaceuticals, Inc. (ELTP)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.193-0.01 (-3.17%)
At close: 3:58PM EDT
People also watch
AMBSONCSIGXTRNNMSTX
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue3/31/20173/31/20163/31/2015
Total Revenue9,637.71512,498.3325,015.246
Cost of Revenue5,898.4054,484.1623,013.592
Gross Profit3,739.318,014.172,001.654
Operating Expenses
Research Development8,301.69312,428.78314,727.472
Selling General and Administrative2,441.1813,236.543,164.159
Non Recurring---
Others352.369665.647616.995
Total Operating Expenses---
Operating Income or Loss-7,355.933-8,316.8-16,506.972
Income from Continuing Operations
Total Other Income/Expenses Net9,537.7237,394.00622,011.559
Earnings Before Interest and Taxes2,181.79-922.7945,504.587
Interest Expense238.223280.67287.231
Income Before Tax1,943.567-1,203.4645,217.356
Income Tax Expense-1,867.614-520.452-3.249
Minority Interest---
Net Income From Continuing Ops3,811.181-683.0125,220.605
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income3,811.181-683.0125,220.605
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares24,525.467-9,968.72728,929.674